Design, development and deployment of a web-based patient registry for rare genetic lipid disorders

Kathryn R. Napier, Amanda J. Hooper, David M. Ng, Lee Render, Damon A. Bell, Jing Pang, Gerald F. Watts, Matthew I. Bellgard, John R. Burnett

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Rare genetic lipid disorders comprise all the monogenic disorders of lipoprotein metabolism with the exception of heterozygous familial hypercholesterolaemia (FH). The creation and maintenance of patient registries is critical for disease monitoring, improving clinical best practice, facilitating research and enabling the development of novel therapeutics, but very few disease-specific rare genetic lipid disorder registries currently exist. Our aim was to design, develop and deploy a web-based patient registry for rare genetic lipid disorders. The Rare Genetic Lipid Disorders Registry is based on the FH Australasia Network (FHAN) Registry, which has been operating since 2015. The Rare Genetic Lipid Disorders Registry was deployed utilising the open-source Rare Disease Registry Framework (RDRF), which enables the efficient customisation and sustainable deployment of web-based registries. The Registry has been designed to capture longitudinal data on 13 rare genetic lipid disorders, with the ability to add more if required in the future. Recruitment of volunteers into the Registry is currently through the Royal Perth Hospital Lipid Disorders Clinic in Western Australia. Although in essence a clinic-based patient registry, the web-based design allows for expansion and distribution across Australia and beyond. Data collated by the Registry may ultimately improve the diagnosis, management and treatment of these conditions.
Original languageEnglish
Pages (from-to)447-452
Number of pages6
JournalPathology
Volume52
Issue number4
DOIs
Publication statusPublished - Jun 2020

Fingerprint

Dive into the research topics of 'Design, development and deployment of a web-based patient registry for rare genetic lipid disorders'. Together they form a unique fingerprint.

Cite this